AVIR Atea Pharmaceuticals, Inc.

Fundamentals / CIK 0001593899 / USD

Atea Pharmaceuticals, Inc. reported $200.7M in total assets and a net loss of $155.4M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open AVIR in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

8 fiscal years (2018 to 2025), reported in USD.

$364.1M$182.0M$0-$187.3MFY 2018 Net Income: -$9.06M2018FY 2019 Net Income: -$14.03M2019FY 2020 Revenue: $48.63MFY 2020 Net Income: -$10.95M2020FY 2021 Revenue: $351.4MFY 2021 Net Income: $121.2M2021FY 2022 Net Income: -$115.9M2022FY 2023 Net Income: -$136.0M2023FY 2024 Net Income: -$168.4M2024FY 2025 Net Income: -$158.3M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue -- -- -- -- $351.4M $48.63M -- --
Research & Development $148.0M $144.1M $114.2M $81.94M $167.2M $38.02M $10.17M $6.67M
Total Operating Expenses $180.9M $192.9M $164.2M $130.7M $213.0M $59.66M $14.61M $9.48M
Operating Income -$180.9M -$192.9M -$164.2M -$130.7M $138.4M -$11.03M -$14.61M -$9.48M
EBITDA -$180.5M -$192.5M -$163.7M -$130.4M $138.4M -$11.01M -$14.59M -$9.46M
Income Before Tax -$164.5M -$167.5M -$134.9M -$119.5M $138.6M -$10.95M -$14.03M --
Income Tax Expense -$6.16M $925K $1.02M -$3.59M $17.40M -- -- --
Net Income -$158.3M -$168.4M -$136.0M -$115.9M $121.2M -$10.95M -$14.03M -$9.06M
Basic EPS -$1.94 -$2.00 -$1.63 -$1.39 $1.46 -$0.51 -$1.39 -$0.90
Diluted EPS -$1.94 -$2.00 -$1.63 -$1.39 $1.37 -$0.51 -$1.39 -$0.90
Basic Shares Outstanding 81.5M 84.3M 83.4M 83.2M 82.8M 21.6M 10.1M 10.0M
Diluted Shares Outstanding 81.5M 84.3M 83.4M 83.2M 88.2M 21.6M 10.1M 10.0M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $27.09M $28.15M $41.13M $47.82M $38.35M $32.27M $29.58M $25.67M
Total Operating Expenses $34.01M $35.10M $48.01M $54.93M $45.57M $41.34M $39.04M $39.03M
Operating Income -$34.01M -$35.10M -$48.01M -$54.93M -$45.57M -$41.34M -$39.04M -$39.03M
EBITDA -$33.91M -$34.99M -$47.90M -$54.83M -$45.46M -$41.24M -$38.94M -$38.92M
Income Before Tax -$32.12M -$32.91M -$45.39M -$51.63M -$41.85M -$36.95M -$34.07M -$33.32M
Income Tax Expense $38K $24K $50K -$6.77M $196K $207K $203K $225K
Net Income -$32.16M -$32.93M -$45.44M -$44.87M -$42.05M -$37.16M -$34.27M -$33.54M
Basic EPS -$0.40 -$0.41 -$0.57 -- -$0.53 -$0.44 -$0.40 --
Diluted EPS -$0.40 -$0.41 -$0.57 -- -$0.53 -$0.44 -$0.40 --
Basic Shares Outstanding 80.2M 80.1M 79.2M -- 79.1M 83.7M 85.2M --
Diluted Shares Outstanding 80.2M 80.1M 79.2M -- 79.1M 83.7M 85.2M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $95.71M $64.70M $143.8M $188.5M $764.4M $850.1M $21.66M
Short-Term Investments $206.1M $390.0M $434.3M $458.2M -- -- --
Cash & Short-Term Investments $301.8M $454.7M $578.1M $646.7M $764.4M $850.1M $21.66M
Total Current Assets $311.0M $462.4M $590.5M $660.9M $772.4M $863.5M $21.91M
Property, Plant & Equipment, Net $457K $873K $1.29M $1.71M $23K $48K $41K
Long-Term Investments -- $0 $0 $0 -- -- --
Other Non-Current Assets $3.14M $197K $1.40M $1.49M $466K $107K $122K
Total Non-Current Assets $4.23M $2.31M $4.51M $5.79M $489K $155K $163K
Total Assets $315.2M $464.7M $595.0M $666.7M $772.9M $863.6M $22.07M
Accounts Payable $12.95M $4.46M $4.25M $2.55M $4.53M $60K $548K
Deferred Revenue (Current) -- -- -- -- -- $301.4M --
Total Current Liabilities $39.78M $18.60M $32.38M $18.48M $56.88M $315.8M $2.44M
Other Non-Current Liabilities -- -- -- -- $5.93M $36K $95K
Total Non-Current Liabilities $0 $7.20M $7.40M $7.66M $5.93M $36K $95K
Total Liabilities $39.78M $25.80M $39.78M $26.14M $62.81M $315.8M $2.53M
Total Debt (incl. Leases) $843K $1.64M $2.40M $3.12M $197K -- --
Common Stock $78K $84K $83K $83K $83K $82K $10K
Retained Earnings -$522.6M -$364.2M -$195.8M -$59.88M $56.03M -$65.16M -$54.21M
Accumulated Other Comp. Income $174K $233K $207K -$684K -- -- --
Total Stockholders' Equity $275.4M $438.9M $555.2M $640.6M $710.1M $547.8M -$49.57M
Total Equity $275.4M $438.9M $555.2M $640.6M $710.1M $547.8M -$49.57M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $97.92M $76.55M $79.32M $95.71M $77.34M $87.72M $119.4M $64.70M
Short-Term Investments $93.28M $142.9M $176.7M $206.1M $252.0M $292.0M $306.0M $390.0M
Cash & Short-Term Investments $191.2M $219.5M $256.0M $301.8M $329.3M $379.7M $425.4M $454.7M
Total Current Assets $200.3M $228.7M $263.2M $311.0M $336.1M $385.6M $433.7M $462.4M
Property, Plant & Equipment, Net $145K $249K $353K $457K $561K $665K $769K $873K
Long-Term Investments -- -- -- -- $0 $0 $0 $0
Other Non-Current Assets $132K $3.05M $3.05M $3.14M $5.47M $4.39M $4.39M $197K
Total Non-Current Assets $438K $3.62M $3.88M $4.23M $6.83M $6.00M $6.26M $2.31M
Total Assets $200.7M $232.3M $267.1M $315.2M $343.0M $391.6M $440.0M $464.7M
Accounts Payable $4.84M $10.06M $9.45M $12.95M $3.52M $8.84M $7.39M $4.46M
Total Current Liabilities $25.02M $28.12M $33.37M $39.78M $20.18M $20.12M $21.75M $18.60M
Total Non-Current Liabilities $0 $0 $0 $0 $7.01M $7.07M $7.13M $7.20M
Total Liabilities $25.02M $28.12M $33.37M $39.78M $27.18M $27.19M $28.88M $25.80M
Total Debt (incl. Leases) $213K $424K $634K $843K $1.04M $1.25M $1.45M $1.64M
Common Stock $80K $80K $80K $78K $78K $81K $85K $84K
Retained Earnings -$633.1M -$600.9M -$568.0M -$522.6M -$477.7M -$435.7M -$398.5M -$364.2M
Accumulated Other Comp. Income -$73K -$96K -$97K $174K $238K $37K $118K $233K
Total Stockholders' Equity $175.7M $204.2M $233.7M $275.4M $315.8M $364.4M $411.1M $438.9M
Total Equity $175.7M $204.2M $233.7M $275.4M $315.8M $364.4M $411.1M $438.9M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$158.3M -$168.4M -$136.0M -$115.9M $121.2M -$10.95M -$14.03M -$9.06M
Depreciation & Amortization $416K $416K $416K $260K $29K $19K $17K $17K
Stock-Based Compensation $20.72M $51.77M $49.43M $46.72M $39.62M $7.46M $624K $414K
Change in Receivables -- -- -- -- -- -$5.82M -- --
Change in Payables $8.49M $206K $1.70M -$1.98M $10.29M -$488K $157K -$90K
Operating Cash Flow -$132.0M -$135.5M -$85.39M -$121.0M -$87.00M $296.7M -$12.83M -$7.91M
Capital Expenditure -- -- -- -$1.94M -$4.0K -$26K -$2.0K -$12K
Free Cash Flow -- -- -- -$122.9M -$87.01M $296.7M -$12.83M -$7.92M
Purchases of Investments -$281.9M -$461.2M -$562.4M -$545.4M -- -- -- --
Investing Cash Flow $188.8M $56.10M $40.30M -$455.4M -$4.0K -$26K -$2.0K -$12K
Common Stock Issued -- -- -- -- $1.47M $27K -- $124K
Share Repurchases -$25.52M $0 -- -- -- -- -- --
Financing Cash Flow -$25.75M $267K $257K $370K $1.47M $531.7M -- $27.48M
Net Change in Cash $31.02M -$79.13M -$44.84M -$576.0M -$85.54M $828.5M -$12.83M $19.56M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$32.16M -$32.93M -$45.44M -$44.87M -$42.05M -$37.16M -$34.27M -$33.54M
Depreciation & Amortization $104K $104K $104K $104K $104K $104K $104K $104K
Stock-Based Compensation $3.47M $3.38M $3.73M $4.58M $4.52M $4.67M $6.95M $14.30M
Change in Payables -$5.21M $612K -$3.50M $9.43M -$5.33M $1.46M $2.93M -$1.33M
Operating Cash Flow -$28.87M -$37.08M -$46.39M -$28.22M -$40.38M -$32.87M -$30.56M -$30.40M
Purchases of Investments -$11.97M -$33.81M -$74.55M -$43.79M -$14.78M -$100.7M -$122.6M -$58.48M
Investing Cash Flow $50.05M $34.31M $29.74M $46.59M $41.30M $15.29M $85.61M -$3.37M
Financing Cash Flow $195K $0 $257K $0 -$11.30M -$14.09M -$347K $0
Net Change in Cash $21.37M -$2.77M -$16.40M $18.37M -$10.38M -$31.67M $54.70M -$33.77M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -- -- -- -- 39.4% -22.7% -- --
Net Profit Margin -- -- -- -- 34.5% -22.5% -- --
Return on Equity (ROE) -57.5% -38.4% -24.5% -18.1% 17.1% -2.0% -- --
Return on Assets (ROA) -50.2% -36.2% -22.9% -17.4% 15.7% -1.3% -63.6% --
Current Ratio 7.82x 24.85x 18.24x 35.77x 13.58x 2.73x 9.00x --
Quick Ratio 7.59x 24.44x 17.86x 35.00x 13.44x 2.69x 8.90x --
Debt to Equity 0.00x 0.00x 0.00x 0.00x 0.00x -- -- --
Revenue Growth (YoY) -- -- -- -- +622.5% -- -- --
Operating Income Growth (YoY) -- -- -- -194.4% -- -- -- --
Net Income Growth (YoY) -- -- -- -195.6% -- -- -- --
EPS Growth (YoY) -- -- -- -195.2% -- -- -- --
Operating Cash Flow Growth (YoY) -- -- -- -- -129.3% -- -- --
Free Cash Flow Growth (YoY) -- -- -- -- -129.3% -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -88.5% -81.0% -72.5% -57.5% -46.6% -37.4% -33.9% -38.4%
Return on Assets (ROA) -77.4% -71.2% -63.5% -50.2% -42.9% -34.8% -31.7% -36.2%
Current Ratio 8.00x 8.13x 7.89x 7.82x 16.66x 19.17x 19.94x 24.85x
Quick Ratio 7.64x 7.80x 7.67x 7.59x 16.32x 18.87x 19.56x 24.44x
Debt to Equity 0.00x 0.00x 0.00x 0.00x 0.00x 0.00x 0.00x 0.00x
Source: SEC EDGAR CompanyFacts (CIK 0001593899) · from December 31, 2018 Data through September 30, 2026 · synced Nov 20, 2026, 05:39 UTC · Open in terminal